Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 201 | 2014 | 9026 | 4.420 |
Why?
|
Meningioma | 71 | 2012 | 1215 | 3.970 |
Why?
|
Neurosurgery | 41 | 2014 | 679 | 3.490 |
Why?
|
Meningeal Neoplasms | 55 | 2012 | 1245 | 3.180 |
Why?
|
Glioma | 84 | 2010 | 3453 | 2.670 |
Why?
|
Hydrocephalus, Normal Pressure | 17 | 2008 | 99 | 2.290 |
Why?
|
Cerebrospinal Fluid Shunts | 14 | 2010 | 195 | 1.570 |
Why?
|
Stereotaxic Techniques | 25 | 2014 | 555 | 1.440 |
Why?
|
Neurosurgical Procedures | 19 | 2011 | 2067 | 1.370 |
Why?
|
Glioblastoma | 52 | 2011 | 3481 | 1.300 |
Why?
|
Astrocytoma | 31 | 2011 | 774 | 1.260 |
Why?
|
Monitoring, Intraoperative | 14 | 2011 | 941 | 1.250 |
Why?
|
Pituitary Neoplasms | 28 | 2007 | 1323 | 1.140 |
Why?
|
Magnetic Resonance Imaging | 90 | 2014 | 36402 | 1.060 |
Why?
|
Craniotomy | 18 | 2011 | 741 | 0.940 |
Why?
|
Magnetic Resonance Spectroscopy | 15 | 2011 | 3769 | 0.900 |
Why?
|
Neuronavigation | 8 | 2011 | 166 | 0.870 |
Why?
|
Neuroma, Acoustic | 17 | 2009 | 458 | 0.700 |
Why?
|
Platelet-Derived Growth Factor | 10 | 2000 | 618 | 0.700 |
Why?
|
Hydrocephalus | 15 | 2010 | 764 | 0.690 |
Why?
|
Brain Diseases | 11 | 2012 | 1545 | 0.690 |
Why?
|
Neovascularization, Pathologic | 19 | 2010 | 2644 | 0.680 |
Why?
|
Adenoma | 18 | 2002 | 2159 | 0.640 |
Why?
|
Supratentorial Neoplasms | 6 | 2010 | 159 | 0.630 |
Why?
|
Surgery, Computer-Assisted | 10 | 2014 | 1002 | 0.630 |
Why?
|
Radiosurgery | 23 | 2010 | 1339 | 0.620 |
Why?
|
Intracranial Pressure | 10 | 2010 | 324 | 0.600 |
Why?
|
Oligodendroglioma | 9 | 2007 | 278 | 0.600 |
Why?
|
Spinal Cord Injuries | 14 | 2008 | 924 | 0.580 |
Why?
|
Receptors, Progesterone | 7 | 2008 | 1129 | 0.570 |
Why?
|
Intraoperative Care | 13 | 2009 | 767 | 0.530 |
Why?
|
Growth Substances | 5 | 2004 | 768 | 0.510 |
Why?
|
Hospitals, University | 3 | 2008 | 564 | 0.500 |
Why?
|
Skull Base Neoplasms | 3 | 2012 | 270 | 0.480 |
Why?
|
Cerebrospinal Fluid | 7 | 2007 | 544 | 0.480 |
Why?
|
Humans | 411 | 2014 | 760617 | 0.480 |
Why?
|
Image Processing, Computer-Assisted | 23 | 2010 | 8998 | 0.470 |
Why?
|
Loss of Heterozygosity | 6 | 2010 | 662 | 0.460 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 9 | 2000 | 178 | 0.430 |
Why?
|
Societies, Medical | 5 | 2014 | 3900 | 0.430 |
Why?
|
Cerebral Ventricles | 11 | 2004 | 542 | 0.420 |
Why?
|
Adult | 198 | 2014 | 220969 | 0.420 |
Why?
|
Cerebellar Neoplasms | 7 | 2008 | 586 | 0.410 |
Why?
|
Epilepsies, Partial | 3 | 2008 | 431 | 0.410 |
Why?
|
Brain | 51 | 2014 | 27101 | 0.410 |
Why?
|
Male | 240 | 2014 | 360358 | 0.400 |
Why?
|
Tumor Cells, Cultured | 22 | 2007 | 6126 | 0.390 |
Why?
|
RNA, Messenger | 26 | 2010 | 12758 | 0.390 |
Why?
|
Mice, Nude | 25 | 2011 | 3605 | 0.380 |
Why?
|
History, 21st Century | 6 | 2014 | 1565 | 0.380 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2010 | 506 | 0.370 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2010 | 8542 | 0.370 |
Why?
|
Middle Aged | 168 | 2014 | 220584 | 0.370 |
Why?
|
Angiogenesis Inhibitors | 10 | 2008 | 2048 | 0.370 |
Why?
|
Female | 226 | 2014 | 392148 | 0.360 |
Why?
|
Spinal Puncture | 5 | 2008 | 282 | 0.360 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2008 | 42 | 0.350 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2008 | 410 | 0.350 |
Why?
|
History, 20th Century | 16 | 2011 | 2764 | 0.340 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2009 | 186 | 0.340 |
Why?
|
Microsurgery | 2 | 2008 | 793 | 0.330 |
Why?
|
Receptors, Androgen | 7 | 1997 | 1079 | 0.330 |
Why?
|
Cerebral Cortex | 12 | 2009 | 5776 | 0.320 |
Why?
|
Imaging, Three-Dimensional | 11 | 2005 | 4058 | 0.320 |
Why?
|
Aged | 132 | 2014 | 169042 | 0.320 |
Why?
|
Ganglioglioma | 3 | 1997 | 36 | 0.320 |
Why?
|
Pituitary Diseases | 4 | 2002 | 135 | 0.310 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2005 | 459 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 27 | 2013 | 9277 | 0.310 |
Why?
|
Cerebrospinal Fluid Pressure | 3 | 2005 | 38 | 0.310 |
Why?
|
Blotting, Northern | 12 | 2001 | 1545 | 0.310 |
Why?
|
Medulloblastoma | 8 | 2006 | 677 | 0.310 |
Why?
|
Anesthesia, Local | 3 | 2000 | 277 | 0.300 |
Why?
|
Integrins | 3 | 2001 | 834 | 0.300 |
Why?
|
Drug Delivery Systems | 5 | 2010 | 2222 | 0.300 |
Why?
|
Peptide Fragments | 8 | 2007 | 5110 | 0.300 |
Why?
|
Tetrazolium Salts | 3 | 1998 | 92 | 0.290 |
Why?
|
Immunohistochemistry | 27 | 2012 | 11069 | 0.290 |
Why?
|
Surgery Department, Hospital | 1 | 2008 | 176 | 0.280 |
Why?
|
Frontal Lobe | 9 | 2005 | 1418 | 0.280 |
Why?
|
Brachytherapy | 13 | 2000 | 1223 | 0.280 |
Why?
|
Endostatins | 7 | 2008 | 168 | 0.280 |
Why?
|
Periodicals as Topic | 2 | 2014 | 1463 | 0.270 |
Why?
|
Neuroglia | 3 | 1997 | 955 | 0.270 |
Why?
|
Thrombophlebitis | 5 | 1987 | 289 | 0.270 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 678 | 0.260 |
Why?
|
International Cooperation | 2 | 2010 | 1421 | 0.260 |
Why?
|
Software | 7 | 2011 | 4431 | 0.260 |
Why?
|
Combined Modality Therapy | 26 | 2010 | 8516 | 0.260 |
Why?
|
Adolescent | 93 | 2012 | 88234 | 0.260 |
Why?
|
Cell Division | 13 | 2004 | 4457 | 0.250 |
Why?
|
Cell Movement | 17 | 2011 | 5200 | 0.250 |
Why?
|
Neoplasm Metastasis | 5 | 2010 | 4910 | 0.250 |
Why?
|
Teratoma | 1 | 2008 | 404 | 0.250 |
Why?
|
Postoperative Complications | 22 | 2008 | 15612 | 0.250 |
Why?
|
Neoplasm Proteins | 6 | 2002 | 3607 | 0.250 |
Why?
|
Gene Expression | 10 | 2010 | 7568 | 0.250 |
Why?
|
Plasminogen | 3 | 2000 | 144 | 0.240 |
Why?
|
Aspartic Acid | 2 | 2004 | 576 | 0.240 |
Why?
|
Receptors, Vitronectin | 2 | 2001 | 46 | 0.240 |
Why?
|
Conscious Sedation | 3 | 2000 | 531 | 0.240 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 823 | 0.240 |
Why?
|
Parietal Lobe | 8 | 2007 | 852 | 0.240 |
Why?
|
Neurology | 5 | 2001 | 780 | 0.230 |
Why?
|
Treatment Outcome | 39 | 2014 | 64568 | 0.230 |
Why?
|
Epilepsy, Frontal Lobe | 2 | 2001 | 24 | 0.230 |
Why?
|
Microsatellite Repeats | 5 | 1999 | 783 | 0.220 |
Why?
|
Iodine Radioisotopes | 7 | 1998 | 1031 | 0.220 |
Why?
|
Endothelial Growth Factors | 4 | 2000 | 673 | 0.220 |
Why?
|
Epilepsy, Temporal Lobe | 5 | 2002 | 389 | 0.220 |
Why?
|
Polymers | 2 | 2010 | 1614 | 0.220 |
Why?
|
Neoplasm Staging | 10 | 2014 | 11116 | 0.220 |
Why?
|
Drainage | 2 | 2008 | 1156 | 0.220 |
Why?
|
Electroencephalography | 18 | 2008 | 6237 | 0.220 |
Why?
|
Epilepsy | 9 | 2014 | 3288 | 0.220 |
Why?
|
Doxorubicin | 1 | 2010 | 2224 | 0.210 |
Why?
|
Medical Oncology | 2 | 2007 | 2317 | 0.210 |
Why?
|
Child, Preschool | 43 | 2014 | 42188 | 0.210 |
Why?
|
Child | 66 | 2014 | 80079 | 0.210 |
Why?
|
Lymphokines | 4 | 2000 | 925 | 0.210 |
Why?
|
Contrast Media | 5 | 2008 | 5305 | 0.210 |
Why?
|
Receptors, Estrogen | 6 | 2008 | 2208 | 0.210 |
Why?
|
Biopsy | 15 | 2008 | 6762 | 0.210 |
Why?
|
Surgical Equipment | 3 | 2004 | 57 | 0.210 |
Why?
|
Fibroblast Growth Factor 2 | 8 | 2008 | 592 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 5 | 2009 | 2801 | 0.210 |
Why?
|
Rats | 32 | 2009 | 23717 | 0.210 |
Why?
|
Magnetic Resonance Angiography | 3 | 2004 | 1431 | 0.210 |
Why?
|
Wounds, Nonpenetrating | 4 | 1994 | 806 | 0.210 |
Why?
|
Stem Cells | 8 | 2009 | 3516 | 0.210 |
Why?
|
Receptors, Growth Factor | 3 | 2000 | 326 | 0.200 |
Why?
|
Antineoplastic Agents | 16 | 2010 | 13635 | 0.200 |
Why?
|
Medical Illustration | 4 | 1991 | 135 | 0.200 |
Why?
|
Dacarbazine | 4 | 2009 | 559 | 0.200 |
Why?
|
Receptors, Cell Surface | 5 | 2000 | 2802 | 0.200 |
Why?
|
Malformations of Cortical Development | 3 | 2014 | 176 | 0.200 |
Why?
|
Prognosis | 28 | 2011 | 29600 | 0.190 |
Why?
|
Magnetoencephalography | 2 | 2006 | 636 | 0.190 |
Why?
|
Pituitary Hormones, Anterior | 3 | 1998 | 56 | 0.190 |
Why?
|
Aged, 80 and over | 42 | 2014 | 58894 | 0.190 |
Why?
|
Pineal Gland | 2 | 1999 | 158 | 0.190 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2001 | 96 | 0.190 |
Why?
|
Preoperative Care | 6 | 2006 | 2241 | 0.190 |
Why?
|
G(M3) Ganglioside | 1 | 2001 | 5 | 0.190 |
Why?
|
Microspheres | 3 | 2010 | 782 | 0.190 |
Why?
|
Xenograft Model Antitumor Assays | 11 | 2011 | 3599 | 0.190 |
Why?
|
Angiostatins | 4 | 2004 | 64 | 0.190 |
Why?
|
Telomerase | 4 | 2007 | 744 | 0.190 |
Why?
|
Neoplasm Transplantation | 14 | 2010 | 2010 | 0.190 |
Why?
|
Animals | 87 | 2014 | 168201 | 0.190 |
Why?
|
Genes, Neurofibromatosis 2 | 2 | 2012 | 122 | 0.190 |
Why?
|
Seizures | 6 | 2012 | 2954 | 0.190 |
Why?
|
Pituitary Gland | 4 | 2001 | 635 | 0.180 |
Why?
|
Nitrobenzenes | 1 | 2000 | 66 | 0.180 |
Why?
|
Hospitals, Pediatric | 2 | 2008 | 1859 | 0.180 |
Why?
|
Brain Mapping | 9 | 2010 | 6634 | 0.180 |
Why?
|
Brain Death | 3 | 1991 | 357 | 0.180 |
Why?
|
Thiazoles | 4 | 2000 | 1517 | 0.180 |
Why?
|
Blood Volume | 1 | 2002 | 547 | 0.180 |
Why?
|
Neurons | 10 | 2012 | 9438 | 0.180 |
Why?
|
History, 19th Century | 6 | 2002 | 718 | 0.180 |
Why?
|
DNA, Satellite | 2 | 2000 | 66 | 0.180 |
Why?
|
Collagen | 4 | 2001 | 2634 | 0.180 |
Why?
|
Ependymoma | 4 | 2007 | 320 | 0.170 |
Why?
|
Cerebrovascular Circulation | 7 | 2004 | 2726 | 0.170 |
Why?
|
Brain Edema | 3 | 1996 | 604 | 0.170 |
Why?
|
Central Nervous System Neoplasms | 4 | 2008 | 915 | 0.170 |
Why?
|
Cell Cycle Proteins | 3 | 2001 | 3447 | 0.170 |
Why?
|
Ureter | 2 | 2013 | 368 | 0.170 |
Why?
|
Gadolinium DTPA | 3 | 2002 | 823 | 0.170 |
Why?
|
Microcomputers | 2 | 2004 | 141 | 0.170 |
Why?
|
Colorimetry | 3 | 1998 | 150 | 0.170 |
Why?
|
Evidence-Based Medicine | 4 | 2005 | 3680 | 0.170 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2010 | 3777 | 0.170 |
Why?
|
Hemangioma, Cavernous | 1 | 2000 | 107 | 0.170 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 318 | 0.170 |
Why?
|
Receptors, Glucocorticoid | 3 | 1997 | 305 | 0.170 |
Why?
|
Disease Progression | 15 | 2012 | 13495 | 0.160 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2000 | 366 | 0.160 |
Why?
|
Apoptosis | 12 | 2007 | 9476 | 0.160 |
Why?
|
Genes, Tumor Suppressor | 3 | 2007 | 1056 | 0.160 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 1999 | 20 | 0.160 |
Why?
|
Spinal Cord Compression | 5 | 1993 | 233 | 0.160 |
Why?
|
Receptors, Parathyroid Hormone | 1 | 2000 | 332 | 0.160 |
Why?
|
Urologic Neoplasms | 2 | 2013 | 314 | 0.160 |
Why?
|
Corpus Callosum | 2 | 1995 | 751 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 8 | 2009 | 3492 | 0.160 |
Why?
|
Mesenchymal Stem Cells | 4 | 2011 | 1642 | 0.160 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2000 | 361 | 0.160 |
Why?
|
Polymerase Chain Reaction | 12 | 2008 | 6074 | 0.160 |
Why?
|
Oxazines | 1 | 2001 | 349 | 0.150 |
Why?
|
Choline | 4 | 2004 | 515 | 0.150 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2000 | 278 | 0.150 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 7 | 1998 | 1068 | 0.150 |
Why?
|
Monitoring, Ambulatory | 1 | 2001 | 355 | 0.150 |
Why?
|
Teaching | 1 | 2006 | 1169 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2014 | 2821 | 0.150 |
Why?
|
DNA, Neoplasm | 9 | 2007 | 1743 | 0.150 |
Why?
|
Isoenzymes | 3 | 2007 | 1687 | 0.150 |
Why?
|
Thromboembolism | 2 | 2002 | 991 | 0.150 |
Why?
|
Microtubule-Associated Proteins | 2 | 2002 | 1074 | 0.150 |
Why?
|
Temporal Lobe | 10 | 2010 | 1695 | 0.150 |
Why?
|
Leukotriene C4 | 1 | 1998 | 79 | 0.150 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2012 | 638 | 0.140 |
Why?
|
Vascular Endothelial Growth Factors | 4 | 2000 | 748 | 0.140 |
Why?
|
Prolactin | 6 | 1999 | 625 | 0.140 |
Why?
|
Oligodendroglia | 1 | 2001 | 538 | 0.140 |
Why?
|
Patient Care Planning | 4 | 2001 | 905 | 0.140 |
Why?
|
Spinal Cord | 11 | 2008 | 1807 | 0.140 |
Why?
|
Intraoperative Complications | 5 | 2007 | 1161 | 0.140 |
Why?
|
Equipment Design | 10 | 2006 | 3501 | 0.140 |
Why?
|
Leadership | 1 | 2007 | 1385 | 0.140 |
Why?
|
X Chromosome | 3 | 1999 | 816 | 0.140 |
Why?
|
Cell Line, Tumor | 18 | 2014 | 16967 | 0.140 |
Why?
|
Space Perception | 1 | 2000 | 465 | 0.140 |
Why?
|
Premedication | 1 | 1998 | 245 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2007 | 717 | 0.140 |
Why?
|
Interferon-beta | 2 | 2009 | 345 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 26 | 2005 | 20556 | 0.140 |
Why?
|
Blotting, Western | 9 | 2012 | 5034 | 0.140 |
Why?
|
Reoperation | 11 | 2014 | 4300 | 0.140 |
Why?
|
Thalidomide | 5 | 2008 | 885 | 0.140 |
Why?
|
User-Computer Interface | 3 | 2001 | 1397 | 0.140 |
Why?
|
Survival Analysis | 15 | 2011 | 10073 | 0.130 |
Why?
|
Receptors, Prolactin | 1 | 1996 | 16 | 0.130 |
Why?
|
Image Enhancement | 6 | 2008 | 2881 | 0.130 |
Why?
|
Endothelium, Vascular | 9 | 2005 | 4433 | 0.130 |
Why?
|
Mice | 36 | 2014 | 81368 | 0.130 |
Why?
|
Subarachnoid Hemorrhage | 10 | 1989 | 1033 | 0.130 |
Why?
|
Gravity Suits | 2 | 2002 | 12 | 0.130 |
Why?
|
Tuberous Sclerosis | 3 | 2012 | 1030 | 0.130 |
Why?
|
Idoxuridine | 4 | 1998 | 111 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2000 | 829 | 0.130 |
Why?
|
Trisomy | 2 | 2012 | 260 | 0.130 |
Why?
|
Pituitary Apoplexy | 2 | 1994 | 29 | 0.130 |
Why?
|
Survival Rate | 17 | 2008 | 12719 | 0.130 |
Why?
|
Heterozygote | 3 | 2003 | 2780 | 0.130 |
Why?
|
Contusions | 2 | 1994 | 79 | 0.130 |
Why?
|
Naloxone | 3 | 1986 | 370 | 0.130 |
Why?
|
Cranial Irradiation | 3 | 1996 | 390 | 0.130 |
Why?
|
Encephalitis | 1 | 1999 | 438 | 0.130 |
Why?
|
Radium | 1 | 1996 | 72 | 0.130 |
Why?
|
Operating Rooms | 2 | 2001 | 789 | 0.120 |
Why?
|
Motor Activity | 6 | 2000 | 2714 | 0.120 |
Why?
|
Transfection | 7 | 2010 | 5766 | 0.120 |
Why?
|
Coloring Agents | 1 | 1998 | 562 | 0.120 |
Why?
|
Infant | 24 | 2014 | 36152 | 0.120 |
Why?
|
Language | 3 | 2004 | 1541 | 0.120 |
Why?
|
Ribosome Subunits, Small, Eukaryotic | 1 | 2014 | 17 | 0.120 |
Why?
|
Ventriculoperitoneal Shunt | 3 | 2014 | 187 | 0.120 |
Why?
|
Dosage Compensation, Genetic | 2 | 1995 | 207 | 0.120 |
Why?
|
Technology Assessment, Biomedical | 2 | 2010 | 306 | 0.120 |
Why?
|
Hormones | 2 | 2005 | 869 | 0.120 |
Why?
|
Hypophysectomy | 4 | 1998 | 114 | 0.120 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2014 | 56 | 0.120 |
Why?
|
Hemangioma | 1 | 2000 | 727 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 11 | 2010 | 17878 | 0.120 |
Why?
|
Cluster Analysis | 4 | 2010 | 2700 | 0.120 |
Why?
|
Receptors, Steroid | 1 | 1995 | 156 | 0.120 |
Why?
|
Sella Turcica | 2 | 1994 | 118 | 0.120 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2009 | 617 | 0.120 |
Why?
|
Gene Expression Profiling | 8 | 2011 | 9417 | 0.120 |
Why?
|
Video Recording | 2 | 1997 | 965 | 0.120 |
Why?
|
Nerve Tissue Proteins | 4 | 2006 | 4408 | 0.120 |
Why?
|
Pregnancy Complications | 2 | 2007 | 2948 | 0.120 |
Why?
|
Cell Survival | 9 | 2009 | 5780 | 0.120 |
Why?
|
Receptors, Dopamine D1 | 1 | 1996 | 292 | 0.120 |
Why?
|
Transcription Factors | 4 | 2010 | 12116 | 0.120 |
Why?
|
Quality of Life | 7 | 2010 | 13347 | 0.110 |
Why?
|
Urothelium | 2 | 2013 | 269 | 0.110 |
Why?
|
Cell Growth Processes | 3 | 2010 | 384 | 0.110 |
Why?
|
Laser Therapy | 4 | 2000 | 1092 | 0.110 |
Why?
|
Practice Guidelines as Topic | 5 | 2005 | 7389 | 0.110 |
Why?
|
Case-Control Studies | 23 | 2011 | 22148 | 0.110 |
Why?
|
Intraoperative Period | 4 | 2002 | 510 | 0.110 |
Why?
|
Hemispherectomy | 1 | 2014 | 41 | 0.110 |
Why?
|
Genes, Retinoblastoma | 1 | 1994 | 125 | 0.110 |
Why?
|
Chromosome Aberrations | 4 | 2006 | 1768 | 0.110 |
Why?
|
Radiodermatitis | 1 | 1994 | 60 | 0.110 |
Why?
|
Rats, Inbred Strains | 7 | 1988 | 2088 | 0.110 |
Why?
|
Genes, BRCA1 | 1 | 1997 | 753 | 0.110 |
Why?
|
Bombesin | 1 | 1993 | 35 | 0.110 |
Why?
|
Diagnosis, Differential | 13 | 2008 | 12966 | 0.110 |
Why?
|
Lactic Acid | 3 | 2009 | 1139 | 0.110 |
Why?
|
Tropism | 4 | 2006 | 44 | 0.110 |
Why?
|
Leg | 3 | 1987 | 1087 | 0.110 |
Why?
|
Receptors, Dopamine D2 | 1 | 1996 | 484 | 0.110 |
Why?
|
Chromosomes, Human, Pair 22 | 3 | 2008 | 346 | 0.110 |
Why?
|
Sulfonamides | 3 | 2008 | 1977 | 0.110 |
Why?
|
Predictive Value of Tests | 9 | 2014 | 15251 | 0.110 |
Why?
|
Diagnostic Imaging | 5 | 2011 | 3527 | 0.110 |
Why?
|
Follow-Up Studies | 26 | 2014 | 39063 | 0.110 |
Why?
|
Craniocerebral Trauma | 2 | 1990 | 490 | 0.110 |
Why?
|
Retrospective Studies | 29 | 2014 | 80566 | 0.110 |
Why?
|
Schools, Medical | 1 | 1999 | 878 | 0.110 |
Why?
|
Fluorescent Dyes | 1 | 2001 | 1901 | 0.100 |
Why?
|
Brain Chemistry | 3 | 2004 | 960 | 0.100 |
Why?
|
Neoplasm Invasiveness | 8 | 2010 | 3593 | 0.100 |
Why?
|
Lumbosacral Region | 2 | 2008 | 293 | 0.100 |
Why?
|
Recurrence | 6 | 2012 | 8426 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2000 | 3705 | 0.100 |
Why?
|
Functional Laterality | 5 | 2014 | 2256 | 0.100 |
Why?
|
Movement Disorders | 3 | 2005 | 459 | 0.100 |
Why?
|
Africa | 1 | 2014 | 710 | 0.100 |
Why?
|
Vitamin A Deficiency | 1 | 1992 | 88 | 0.100 |
Why?
|
Testicular Neoplasms | 2 | 2010 | 800 | 0.100 |
Why?
|
Genomics | 2 | 2007 | 5822 | 0.100 |
Why?
|
Karnofsky Performance Status | 2 | 2010 | 166 | 0.100 |
Why?
|
Pituitary Hormones | 3 | 1988 | 182 | 0.100 |
Why?
|
Hamartoma | 1 | 1994 | 235 | 0.100 |
Why?
|
Scalp | 2 | 1998 | 389 | 0.100 |
Why?
|
Nerve Regeneration | 3 | 2008 | 796 | 0.100 |
Why?
|
Visual Perception | 1 | 2000 | 1388 | 0.100 |
Why?
|
Sensitivity and Specificity | 11 | 2008 | 14648 | 0.100 |
Why?
|
Spinal Diseases | 2 | 1994 | 561 | 0.100 |
Why?
|
Reproducibility of Results | 11 | 2011 | 20074 | 0.100 |
Why?
|
Matrix Metalloproteinases | 2 | 2007 | 391 | 0.100 |
Why?
|
Vitronectin | 2 | 2001 | 40 | 0.100 |
Why?
|
Proteins | 4 | 2001 | 6030 | 0.100 |
Why?
|
Oculomotor Nerve Diseases | 1 | 1992 | 54 | 0.100 |
Why?
|
Managed Care Programs | 1 | 1997 | 937 | 0.100 |
Why?
|
Disease Models, Animal | 16 | 2011 | 18221 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2010 | 1784 | 0.090 |
Why?
|
Research | 3 | 2007 | 1977 | 0.090 |
Why?
|
Pseudotumor Cerebri | 1 | 1992 | 108 | 0.090 |
Why?
|
Anticonvulsants | 3 | 2012 | 1906 | 0.090 |
Why?
|
Transplantation, Heterologous | 6 | 2006 | 2382 | 0.090 |
Why?
|
Pressure | 4 | 1987 | 1150 | 0.090 |
Why?
|
Boston | 8 | 2010 | 9313 | 0.090 |
Why?
|
Chromosomal Instability | 1 | 2012 | 178 | 0.090 |
Why?
|
Hematoma, Subdural | 2 | 1985 | 127 | 0.090 |
Why?
|
Cerebrum | 1 | 2012 | 132 | 0.090 |
Why?
|
Thallium Radioisotopes | 4 | 1998 | 138 | 0.090 |
Why?
|
Congresses as Topic | 2 | 2014 | 802 | 0.090 |
Why?
|
Polymorphism, Genetic | 4 | 2010 | 4242 | 0.090 |
Why?
|
Nerve Compression Syndromes | 1 | 1992 | 160 | 0.090 |
Why?
|
Craniopharyngioma | 3 | 2007 | 276 | 0.090 |
Why?
|
Models, Biological | 6 | 2007 | 9461 | 0.090 |
Why?
|
HLA-DQ Antigens | 1 | 2010 | 191 | 0.090 |
Why?
|
Disease-Free Survival | 8 | 2014 | 6807 | 0.090 |
Why?
|
Polyglycolic Acid | 2 | 2009 | 406 | 0.090 |
Why?
|
Neurilemmoma | 2 | 2006 | 524 | 0.090 |
Why?
|
Nervous System Physiological Phenomena | 1 | 1991 | 114 | 0.090 |
Why?
|
Patient Selection | 5 | 2010 | 4237 | 0.090 |
Why?
|
Forecasting | 4 | 2007 | 2924 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2010 | 3356 | 0.090 |
Why?
|
DNA Repair Enzymes | 2 | 2009 | 346 | 0.090 |
Why?
|
Methacrylates | 1 | 2010 | 109 | 0.080 |
Why?
|
Epidermal Cyst | 1 | 1990 | 64 | 0.080 |
Why?
|
Proportional Hazards Models | 6 | 2013 | 12447 | 0.080 |
Why?
|
Stem Cell Transplantation | 4 | 2009 | 1600 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 7 | 2008 | 8166 | 0.080 |
Why?
|
Time Factors | 18 | 2013 | 39913 | 0.080 |
Why?
|
Sphenoid Bone | 2 | 2002 | 177 | 0.080 |
Why?
|
Drug Stability | 1 | 2010 | 291 | 0.080 |
Why?
|
Electromagnetic Fields | 2 | 2009 | 289 | 0.080 |
Why?
|
Reference Values | 5 | 2003 | 4919 | 0.080 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 58 | 0.080 |
Why?
|
Seminoma | 1 | 2010 | 134 | 0.080 |
Why?
|
Legislation as Topic | 3 | 2005 | 76 | 0.080 |
Why?
|
Art | 1 | 1990 | 64 | 0.080 |
Why?
|
Pregnancy | 5 | 2007 | 29868 | 0.080 |
Why?
|
Gene Deletion | 5 | 2012 | 2661 | 0.080 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 602 | 0.080 |
Why?
|
Alternative Splicing | 2 | 2012 | 1088 | 0.080 |
Why?
|
Genetic Markers | 4 | 2003 | 2601 | 0.080 |
Why?
|
Transcription, Genetic | 4 | 1999 | 7583 | 0.080 |
Why?
|
Puberty, Precocious | 1 | 1990 | 164 | 0.080 |
Why?
|
Titanium | 1 | 2011 | 485 | 0.080 |
Why?
|
Surgical Mesh | 1 | 2011 | 311 | 0.080 |
Why?
|
Algorithms | 7 | 2008 | 14018 | 0.080 |
Why?
|
Arizona | 5 | 2006 | 107 | 0.080 |
Why?
|
Suppression, Genetic | 1 | 1989 | 190 | 0.080 |
Why?
|
Occupational Exposure | 3 | 2009 | 1813 | 0.080 |
Why?
|
Immunoenzyme Techniques | 6 | 1996 | 1703 | 0.080 |
Why?
|
Epilepsy, Complex Partial | 1 | 2008 | 56 | 0.080 |
Why?
|
Acrylamides | 1 | 2010 | 259 | 0.080 |
Why?
|
Radiography | 7 | 2008 | 6961 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2013 | 6474 | 0.080 |
Why?
|
Nerve Tissue | 1 | 1988 | 78 | 0.070 |
Why?
|
Catalase | 1 | 2008 | 218 | 0.070 |
Why?
|
Biopsy, Needle | 3 | 2014 | 1624 | 0.070 |
Why?
|
Neural Inhibition | 1 | 2012 | 588 | 0.070 |
Why?
|
Ultrasonic Therapy | 1 | 2010 | 215 | 0.070 |
Why?
|
Lymph Node Excision | 2 | 2012 | 1269 | 0.070 |
Why?
|
Nephrectomy | 1 | 2013 | 937 | 0.070 |
Why?
|
Hypersensitivity | 2 | 2011 | 1167 | 0.070 |
Why?
|
Models, Neurological | 3 | 2003 | 1768 | 0.070 |
Why?
|
Nicardipine | 1 | 1988 | 60 | 0.070 |
Why?
|
Somatomedins | 1 | 2008 | 179 | 0.070 |
Why?
|
Resource Allocation | 1 | 1990 | 350 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2008 | 10754 | 0.070 |
Why?
|
Nitrosourea Compounds | 1 | 2007 | 32 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 1999 | 1924 | 0.070 |
Why?
|
RNA, Neoplasm | 5 | 2007 | 749 | 0.070 |
Why?
|
Foreign Medical Graduates | 2 | 1978 | 77 | 0.070 |
Why?
|
Tumor Burden | 2 | 2010 | 1892 | 0.070 |
Why?
|
Awards and Prizes | 1 | 2012 | 360 | 0.070 |
Why?
|
Receptors, Mitogen | 1 | 1987 | 61 | 0.070 |
Why?
|
Gliosarcoma | 2 | 1998 | 114 | 0.070 |
Why?
|
Protein Biosynthesis | 1 | 2014 | 2100 | 0.070 |
Why?
|
Ependyma | 1 | 1987 | 56 | 0.070 |
Why?
|
Cerebral Decortication | 2 | 1998 | 11 | 0.070 |
Why?
|
Receptors, Glutamate | 1 | 2008 | 227 | 0.070 |
Why?
|
Base Sequence | 7 | 2008 | 12421 | 0.070 |
Why?
|
Microscopy, Electron, Scanning | 4 | 2007 | 944 | 0.070 |
Why?
|
Statistics as Topic | 4 | 2004 | 2358 | 0.070 |
Why?
|
Platelet Factor 4 | 1 | 2007 | 129 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2007 | 53 | 0.070 |
Why?
|
Genes, cdc | 1 | 2007 | 114 | 0.070 |
Why?
|
Pennsylvania | 5 | 2006 | 612 | 0.070 |
Why?
|
Olivary Nucleus | 1 | 2008 | 128 | 0.070 |
Why?
|
Receptors, Opioid, mu | 1 | 2008 | 167 | 0.070 |
Why?
|
Hair Dyes | 1 | 2006 | 30 | 0.070 |
Why?
|
Stathmin | 1 | 2007 | 70 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2010 | 943 | 0.070 |
Why?
|
Receptor, EphA2 | 1 | 2006 | 41 | 0.070 |
Why?
|
International Educational Exchange | 1 | 2007 | 49 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2010 | 15908 | 0.070 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2007 | 92 | 0.070 |
Why?
|
Etanidazole | 2 | 1998 | 22 | 0.070 |
Why?
|
DNA Primers | 3 | 2007 | 2817 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2000 | 4935 | 0.070 |
Why?
|
Microcirculation | 4 | 2004 | 1272 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2007 | 697 | 0.070 |
Why?
|
Glycine | 1 | 2010 | 661 | 0.070 |
Why?
|
Hypertrophy | 2 | 2008 | 560 | 0.070 |
Why?
|
Programming Languages | 1 | 2007 | 129 | 0.070 |
Why?
|
Neurofibromin 2 | 1 | 2007 | 270 | 0.070 |
Why?
|
Fibrinolysis | 1 | 1987 | 331 | 0.070 |
Why?
|
Ethics, Medical | 3 | 1997 | 783 | 0.070 |
Why?
|
Hydrocarbons, Aromatic | 1 | 2006 | 23 | 0.070 |
Why?
|
Liposomes | 1 | 2010 | 784 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2008 | 1493 | 0.070 |
Why?
|
Ischemic Attack, Transient | 4 | 1986 | 874 | 0.070 |
Why?
|
Surgical Wound Infection | 2 | 2011 | 1529 | 0.070 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.070 |
Why?
|
Epidermal Growth Factor | 3 | 2010 | 699 | 0.070 |
Why?
|
Porphobilinogen Synthase | 1 | 2005 | 27 | 0.060 |
Why?
|
Antibodies, Monoclonal | 4 | 2001 | 9172 | 0.060 |
Why?
|
Remission Induction | 3 | 2008 | 2391 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 709 | 0.060 |
Why?
|
Radiotherapy Dosage | 9 | 2005 | 2897 | 0.060 |
Why?
|
Extracellular Matrix | 2 | 2006 | 1718 | 0.060 |
Why?
|
Altitude Sickness | 1 | 1986 | 91 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2008 | 593 | 0.060 |
Why?
|
Subtraction Technique | 2 | 2008 | 512 | 0.060 |
Why?
|
Epilepsy, Partial, Sensory | 1 | 2005 | 1 | 0.060 |
Why?
|
China | 1 | 2012 | 2374 | 0.060 |
Why?
|
Molecular Sequence Data | 7 | 2008 | 17629 | 0.060 |
Why?
|
Stem Cell Niche | 1 | 2009 | 344 | 0.060 |
Why?
|
Neurogenesis | 1 | 2012 | 862 | 0.060 |
Why?
|
General Surgery | 1 | 1997 | 1692 | 0.060 |
Why?
|
Dysgeusia | 1 | 2005 | 15 | 0.060 |
Why?
|
Cytosine Deaminase | 4 | 2009 | 66 | 0.060 |
Why?
|
Neoplasm, Residual | 3 | 2002 | 1008 | 0.060 |
Why?
|
Blood Vessels | 2 | 2001 | 1113 | 0.060 |
Why?
|
Luteinizing Hormone | 2 | 1987 | 820 | 0.060 |
Why?
|
Spinal Fusion | 2 | 1993 | 1275 | 0.060 |
Why?
|
Household Articles | 1 | 2005 | 21 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2456 | 0.060 |
Why?
|
Tourniquets | 1 | 1986 | 107 | 0.060 |
Why?
|
Emigration and Immigration | 2 | 1978 | 397 | 0.060 |
Why?
|
Models, Anatomic | 2 | 1999 | 683 | 0.060 |
Why?
|
Age Distribution | 3 | 2006 | 2871 | 0.060 |
Why?
|
Vagus Nerve Stimulation | 1 | 2008 | 229 | 0.060 |
Why?
|
Neuropeptides | 1 | 1991 | 944 | 0.060 |
Why?
|
United States | 16 | 2007 | 72272 | 0.060 |
Why?
|
Thrombospondins | 2 | 2008 | 193 | 0.060 |
Why?
|
Prospective Studies | 11 | 2010 | 54360 | 0.060 |
Why?
|
History, 18th Century | 2 | 2001 | 206 | 0.060 |
Why?
|
Risk Factors | 16 | 2013 | 74115 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2001 | 9586 | 0.060 |
Why?
|
Basilar Artery | 2 | 1984 | 205 | 0.060 |
Why?
|
Lipid Metabolism | 2 | 2004 | 1896 | 0.060 |
Why?
|
Electrolytes | 1 | 1985 | 274 | 0.060 |
Why?
|
Microscopy, Fluorescence | 4 | 2009 | 2639 | 0.060 |
Why?
|
Actuarial Analysis | 3 | 1999 | 372 | 0.060 |
Why?
|
Therapy, Computer-Assisted | 2 | 1999 | 266 | 0.060 |
Why?
|
Genetic Testing | 1 | 1998 | 3533 | 0.060 |
Why?
|
Prolactinoma | 2 | 1999 | 114 | 0.060 |
Why?
|
Immunoglobulin E | 1 | 2011 | 1502 | 0.060 |
Why?
|
Fibroblast Growth Factors | 2 | 2000 | 865 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2007 | 457 | 0.060 |
Why?
|
Piperazines | 2 | 2009 | 2521 | 0.060 |
Why?
|
Microvessels | 1 | 2009 | 577 | 0.060 |
Why?
|
Confidence Intervals | 3 | 2005 | 2925 | 0.060 |
Why?
|
Mathematical Computing | 1 | 2004 | 142 | 0.060 |
Why?
|
Cells, Cultured | 10 | 2011 | 18937 | 0.060 |
Why?
|
DNA Probes | 2 | 1995 | 541 | 0.060 |
Why?
|
Young Adult | 9 | 2012 | 59179 | 0.060 |
Why?
|
Oncogenic Viruses | 1 | 2004 | 37 | 0.060 |
Why?
|
Calcium Channel Blockers | 1 | 1988 | 694 | 0.060 |
Why?
|
Radiology, Interventional | 2 | 1999 | 476 | 0.060 |
Why?
|
Clone Cells | 3 | 1999 | 1657 | 0.060 |
Why?
|
Sulfasalazine | 1 | 2004 | 84 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 2010 | 1182 | 0.060 |
Why?
|
Vocabulary | 1 | 2005 | 166 | 0.060 |
Why?
|
Pulmonary Embolism | 4 | 1993 | 2568 | 0.060 |
Why?
|
Software Design | 1 | 2004 | 171 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2014 | 11736 | 0.060 |
Why?
|
Cysts | 1 | 1989 | 680 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2007 | 481 | 0.060 |
Why?
|
Age Factors | 9 | 2014 | 18381 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1997 | 767 | 0.060 |
Why?
|
Arteriovenous Malformations | 2 | 2005 | 396 | 0.060 |
Why?
|
Health Resources | 1 | 1990 | 933 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 4570 | 0.060 |
Why?
|
Vestibular Diseases | 1 | 2006 | 231 | 0.060 |
Why?
|
Morphine | 1 | 2008 | 655 | 0.060 |
Why?
|
Cell Adhesion | 4 | 2006 | 3088 | 0.060 |
Why?
|
Stromal Cells | 1 | 2009 | 1329 | 0.060 |
Why?
|
Euthanasia, Passive | 2 | 1984 | 64 | 0.060 |
Why?
|
Diffusion | 2 | 2004 | 814 | 0.060 |
Why?
|
Risk | 9 | 2006 | 9604 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 1998 | 3194 | 0.060 |
Why?
|
Specialization | 2 | 2007 | 778 | 0.060 |
Why?
|
Behavioral Symptoms | 1 | 2005 | 186 | 0.060 |
Why?
|
Pituitary Gland, Anterior | 3 | 1994 | 142 | 0.060 |
Why?
|
Genome, Human | 2 | 2006 | 4421 | 0.050 |
Why?
|
Hot Temperature | 1 | 2010 | 1437 | 0.050 |
Why?
|
Corneal Neovascularization | 1 | 2005 | 185 | 0.050 |
Why?
|
Injections, Subcutaneous | 2 | 2005 | 671 | 0.050 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2003 | 25 | 0.050 |
Why?
|
Methylation | 4 | 2006 | 1077 | 0.050 |
Why?
|
Laminin | 2 | 2006 | 408 | 0.050 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2003 | 35 | 0.050 |
Why?
|
Gene Targeting | 1 | 2006 | 837 | 0.050 |
Why?
|
Pyrimidines | 2 | 2009 | 3027 | 0.050 |
Why?
|
Cell Transplantation | 2 | 2005 | 472 | 0.050 |
Why?
|
Neurologic Examination | 3 | 1997 | 915 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2010 | 10432 | 0.050 |
Why?
|
Urinary Incontinence | 2 | 1985 | 489 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2006 | 561 | 0.050 |
Why?
|
Creatine | 1 | 2004 | 427 | 0.050 |
Why?
|
Judgment | 1 | 2005 | 272 | 0.050 |
Why?
|
Astrocytes | 2 | 2000 | 1341 | 0.050 |
Why?
|
Dementia | 2 | 1989 | 2680 | 0.050 |
Why?
|
Growth Inhibitors | 2 | 2000 | 375 | 0.050 |
Why?
|
Paralysis | 2 | 1997 | 250 | 0.050 |
Why?
|
Feasibility Studies | 4 | 2007 | 5239 | 0.050 |
Why?
|
Integrin alphaVbeta3 | 1 | 2003 | 105 | 0.050 |
Why?
|
Odds Ratio | 8 | 2010 | 9643 | 0.050 |
Why?
|
Robotics | 1 | 2009 | 816 | 0.050 |
Why?
|
Neurosciences | 1 | 2007 | 367 | 0.050 |
Why?
|
Heparin | 3 | 2002 | 1632 | 0.050 |
Why?
|
Neuroendocrine Tumors | 1 | 2008 | 641 | 0.050 |
Why?
|
Computer Systems | 3 | 1999 | 469 | 0.050 |
Why?
|
Abducens Nerve | 1 | 1981 | 28 | 0.050 |
Why?
|
Cell Death | 2 | 2001 | 1677 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2014 | 2223 | 0.050 |
Why?
|
Bioreactors | 1 | 2003 | 246 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2409 | 0.050 |
Why?
|
Dominance, Cerebral | 4 | 1997 | 623 | 0.050 |
Why?
|
Rats, Inbred F344 | 7 | 2000 | 826 | 0.050 |
Why?
|
Parathyroid Hormone-Related Protein | 2 | 2000 | 327 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2327 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3410 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2000 | 1626 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 188 | 0.050 |
Why?
|
Artifacts | 2 | 2008 | 1910 | 0.050 |
Why?
|
Cavernous Sinus | 2 | 1992 | 123 | 0.050 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2006 | 491 | 0.050 |
Why?
|
Social Change | 1 | 2002 | 153 | 0.050 |
Why?
|
Etoposide | 3 | 2010 | 634 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2001 | 6520 | 0.050 |
Why?
|
Receptors, TIE | 1 | 2000 | 10 | 0.050 |
Why?
|
Psychosurgery | 1 | 2001 | 86 | 0.050 |
Why?
|
Hyperthermia, Induced | 3 | 2000 | 417 | 0.050 |
Why?
|
Nucleoside Deaminases | 1 | 2000 | 58 | 0.050 |
Why?
|
Safety Management | 1 | 2007 | 760 | 0.050 |
Why?
|
Neoplasms | 4 | 2014 | 22131 | 0.050 |
Why?
|
Suramin | 1 | 2000 | 34 | 0.050 |
Why?
|
Tissue Distribution | 3 | 2001 | 2261 | 0.050 |
Why?
|
Bandages | 1 | 2002 | 269 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2000 | 46 | 0.050 |
Why?
|
Protons | 4 | 2008 | 1112 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2000 | 42 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2000 | 75 | 0.050 |
Why?
|
History, 17th Century | 1 | 2001 | 108 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2005 | 1336 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2000 | 40 | 0.050 |
Why?
|
Electromagnetic Phenomena | 1 | 2002 | 160 | 0.050 |
Why?
|
Lead | 1 | 2006 | 879 | 0.050 |
Why?
|
SEER Program | 1 | 2006 | 1450 | 0.050 |
Why?
|
Ion Channels | 1 | 1985 | 1039 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2007 | 1208 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2003 | 565 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2001 | 266 | 0.050 |
Why?
|
Endorphins | 3 | 1985 | 74 | 0.040 |
Why?
|
England | 1 | 2002 | 526 | 0.040 |
Why?
|
Membrane Potentials | 4 | 2008 | 1089 | 0.040 |
Why?
|
Peptides, Cyclic | 1 | 2003 | 392 | 0.040 |
Why?
|
Polylysine | 1 | 2001 | 131 | 0.040 |
Why?
|
Memory | 3 | 2005 | 2192 | 0.040 |
Why?
|
Occupations | 1 | 2003 | 516 | 0.040 |
Why?
|
Capsules | 1 | 2001 | 191 | 0.040 |
Why?
|
Outpatients | 1 | 2008 | 1596 | 0.040 |
Why?
|
Animals, Newborn | 2 | 1998 | 2668 | 0.040 |
Why?
|
Nervous System | 1 | 2003 | 545 | 0.040 |
Why?
|
DNA Repair | 1 | 2009 | 2043 | 0.040 |
Why?
|
Risk Assessment | 5 | 2010 | 23972 | 0.040 |
Why?
|
Cyclohexanes | 1 | 2000 | 152 | 0.040 |
Why?
|
Transgenes | 1 | 2003 | 1008 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2000 | 53 | 0.040 |
Why?
|
Enoxaparin | 1 | 2002 | 391 | 0.040 |
Why?
|
Logistic Models | 6 | 2011 | 13245 | 0.040 |
Why?
|
Angiopoietin-1 | 1 | 2000 | 122 | 0.040 |
Why?
|
DNA Methylation | 4 | 2009 | 4391 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2004 | 702 | 0.040 |
Why?
|
Receptor, TIE-2 | 1 | 2000 | 176 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 2000 | 135 | 0.040 |
Why?
|
Military Medicine | 1 | 2002 | 184 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2008 | 1204 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5789 | 0.040 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 329 | 0.040 |
Why?
|
Peroxisomes | 1 | 2000 | 68 | 0.040 |
Why?
|
Sesquiterpenes | 1 | 2000 | 176 | 0.040 |
Why?
|
Microscopy, Electron | 6 | 1998 | 2561 | 0.040 |
Why?
|
Culture Media | 1 | 2001 | 895 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2000 | 172 | 0.040 |
Why?
|
Retinoids | 1 | 2000 | 99 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 1433 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 1201 | 0.040 |
Why?
|
Ganglioneuroma | 1 | 1999 | 53 | 0.040 |
Why?
|
Microwaves | 1 | 2001 | 184 | 0.040 |
Why?
|
Pinealoma | 1 | 1999 | 52 | 0.040 |
Why?
|
Alginates | 1 | 2001 | 248 | 0.040 |
Why?
|
Pilot Projects | 4 | 2008 | 8618 | 0.040 |
Why?
|
Germany | 1 | 2001 | 872 | 0.040 |
Why?
|
Monitoring, Physiologic | 3 | 1996 | 1779 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2849 | 0.040 |
Why?
|
Self-Assessment | 1 | 2001 | 398 | 0.040 |
Why?
|
Pituitary Function Tests | 1 | 1998 | 24 | 0.040 |
Why?
|
Euthanasia | 1 | 1979 | 58 | 0.040 |
Why?
|
Intracranial Aneurysm | 2 | 1986 | 1285 | 0.040 |
Why?
|
Pneumocephalus | 1 | 1979 | 47 | 0.040 |
Why?
|
Endocrine System Diseases | 2 | 1998 | 249 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2005 | 1386 | 0.040 |
Why?
|
Alzheimer Disease | 3 | 2002 | 8601 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 4 | 2006 | 1301 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2011 | 14591 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2000 | 329 | 0.040 |
Why?
|
Tissue Survival | 1 | 1998 | 119 | 0.040 |
Why?
|
Pain, Intractable | 1 | 1979 | 132 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1999 | 319 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6305 | 0.040 |
Why?
|
Cisplatin | 2 | 2010 | 1650 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2000 | 335 | 0.040 |
Why?
|
Medical Errors | 1 | 2007 | 1263 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2008 | 4308 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2000 | 321 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2000 | 3514 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2004 | 4512 | 0.040 |
Why?
|
Seasons | 1 | 2004 | 1518 | 0.040 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 110 | 0.040 |
Why?
|
Protein Subunits | 2 | 2014 | 942 | 0.040 |
Why?
|
Fluorescence | 1 | 2001 | 756 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 1999 | 168 | 0.040 |
Why?
|
Internet | 1 | 2010 | 3090 | 0.040 |
Why?
|
Water | 1 | 2004 | 1409 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1528 | 0.040 |
Why?
|
Spinal Cord Diseases | 2 | 1978 | 291 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2000 | 596 | 0.040 |
Why?
|
Meningomyelocele | 1 | 1979 | 171 | 0.040 |
Why?
|
Clinical Trials as Topic | 7 | 2007 | 7995 | 0.040 |
Why?
|
Clinical Protocols | 2 | 2008 | 1437 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2002 | 945 | 0.040 |
Why?
|
Hemodynamics | 2 | 1987 | 4160 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2011 | 695 | 0.040 |
Why?
|
Arachnoid Cysts | 1 | 1998 | 61 | 0.040 |
Why?
|
Hemiplegia | 2 | 1995 | 136 | 0.040 |
Why?
|
Capillaries | 1 | 2001 | 756 | 0.040 |
Why?
|
Spinal Cord Neoplasms | 1 | 1979 | 261 | 0.040 |
Why?
|
Radiotherapy, Conformal | 1 | 2001 | 548 | 0.040 |
Why?
|
Rabbits | 5 | 1992 | 4770 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2001 | 1989 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2000 | 540 | 0.040 |
Why?
|
Telephone | 1 | 2001 | 626 | 0.040 |
Why?
|
Oligopeptides | 1 | 2003 | 1185 | 0.040 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 2 | 2008 | 83 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2008 | 3113 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2000 | 460 | 0.040 |
Why?
|
Gatekeeping | 1 | 1997 | 49 | 0.040 |
Why?
|
Confusion | 1 | 1999 | 278 | 0.040 |
Why?
|
Cricetinae | 1 | 2001 | 2424 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2000 | 664 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 1 | 2001 | 2467 | 0.030 |
Why?
|
Cerebral Hemorrhage | 2 | 2007 | 2641 | 0.030 |
Why?
|
Inpatients | 1 | 2008 | 2544 | 0.030 |
Why?
|
Tokyo | 1 | 1996 | 25 | 0.030 |
Why?
|
Jurisprudence | 1 | 1997 | 109 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 1998 | 1157 | 0.030 |
Why?
|
Spin Labels | 2 | 2008 | 337 | 0.030 |
Why?
|
Endopeptidases | 1 | 2000 | 774 | 0.030 |
Why?
|
Dopamine | 3 | 1990 | 1606 | 0.030 |
Why?
|
Necrosis | 4 | 2000 | 1610 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2000 | 394 | 0.030 |
Why?
|
Cell Line | 7 | 2009 | 15576 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2002 | 725 | 0.030 |
Why?
|
Phosphotyrosine | 1 | 1997 | 456 | 0.030 |
Why?
|
Cognition | 3 | 2005 | 6987 | 0.030 |
Why?
|
Decision Making | 2 | 2008 | 3918 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 1999 | 658 | 0.030 |
Why?
|
Fibronectins | 1 | 2000 | 723 | 0.030 |
Why?
|
Multivariate Analysis | 4 | 2013 | 12043 | 0.030 |
Why?
|
Economics | 1 | 1997 | 141 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2001 | 969 | 0.030 |
Why?
|
Antibodies, Neoplasm | 1 | 1997 | 280 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2009 | 3548 | 0.030 |
Why?
|
Bromocriptine | 3 | 1999 | 93 | 0.030 |
Why?
|
Incidence | 5 | 2005 | 21337 | 0.030 |
Why?
|
Promegestone | 1 | 1995 | 9 | 0.030 |
Why?
|
Phosphoglycerate Kinase | 1 | 1995 | 66 | 0.030 |
Why?
|
Tyrosine Transaminase | 1 | 1995 | 11 | 0.030 |
Why?
|
Learning | 1 | 1985 | 1740 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1998 | 349 | 0.030 |
Why?
|
Antigens, Neoplasm | 2 | 2006 | 1985 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2004 | 1490 | 0.030 |
Why?
|
Utah | 2 | 2006 | 129 | 0.030 |
Why?
|
NF-kappa B | 1 | 2004 | 2481 | 0.030 |
Why?
|
Hypothalamus | 3 | 1990 | 999 | 0.030 |
Why?
|
Hospital Charges | 1 | 1997 | 350 | 0.030 |
Why?
|
Nervous System Diseases | 2 | 2002 | 1662 | 0.030 |
Why?
|
Progesterone Congeners | 1 | 1995 | 44 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 858 | 0.030 |
Why?
|
Pediatrics | 1 | 1991 | 3588 | 0.030 |
Why?
|
Mannitol | 1 | 1996 | 177 | 0.030 |
Why?
|
Acromegaly | 1 | 1998 | 310 | 0.030 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1995 | 221 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 1997 | 329 | 0.030 |
Why?
|
Peptides | 2 | 1990 | 4354 | 0.030 |
Why?
|
Paresthesia | 1 | 1996 | 162 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2006 | 2756 | 0.030 |
Why?
|
Pharyngeal Diseases | 1 | 1996 | 134 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2001 | 1133 | 0.030 |
Why?
|
Surgical Flaps | 2 | 1994 | 1670 | 0.030 |
Why?
|
Organotechnetium Compounds | 2 | 1994 | 129 | 0.030 |
Why?
|
Electrodes | 1 | 1997 | 610 | 0.030 |
Why?
|
Oncogene Proteins v-fos | 1 | 1994 | 15 | 0.030 |
Why?
|
Hypnotics and Sedatives | 2 | 2000 | 1178 | 0.030 |
Why?
|
Cattle | 1 | 2001 | 3841 | 0.030 |
Why?
|
Hindlimb | 2 | 1988 | 513 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2006 | 3461 | 0.030 |
Why?
|
Swine | 2 | 2005 | 5907 | 0.030 |
Why?
|
Alleles | 2 | 1998 | 6861 | 0.030 |
Why?
|
Thymidine Kinase | 1 | 1995 | 286 | 0.030 |
Why?
|
Sex Factors | 5 | 2014 | 10548 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 1999 | 583 | 0.030 |
Why?
|
Actins | 2 | 2000 | 2050 | 0.030 |
Why?
|
Bone Marrow Transplantation | 2 | 1996 | 2690 | 0.030 |
Why?
|
Length of Stay | 1 | 2008 | 6418 | 0.030 |
Why?
|
Patient Advocacy | 1 | 1997 | 360 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 2864 | 0.030 |
Why?
|
Interview, Psychological | 1 | 1998 | 809 | 0.030 |
Why?
|
Environmental Exposure | 2 | 2006 | 4483 | 0.030 |
Why?
|
Chemotaxis | 2 | 2009 | 598 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 1992 | 6340 | 0.030 |
Why?
|
Electric Stimulation | 3 | 1995 | 1734 | 0.030 |
Why?
|
Computer Simulation | 3 | 2011 | 6233 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2000 | 4110 | 0.030 |
Why?
|
Eosinophils | 1 | 1999 | 953 | 0.030 |
Why?
|
Peripheral Nerves | 2 | 2008 | 479 | 0.030 |
Why?
|
Pituitary Irradiation | 1 | 1994 | 14 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2006 | 26180 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2014 | 156 | 0.030 |
Why?
|
Li-Fraumeni Syndrome | 1 | 1995 | 117 | 0.030 |
Why?
|
Culture Media, Conditioned | 2 | 2006 | 522 | 0.030 |
Why?
|
Molecular Probes | 1 | 1996 | 309 | 0.030 |
Why?
|
Developing Countries | 1 | 2007 | 2867 | 0.030 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1994 | 56 | 0.030 |
Why?
|
British Columbia | 1 | 2014 | 241 | 0.030 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2011 | 499 | 0.030 |
Why?
|
Genes, p16 | 2 | 2007 | 160 | 0.030 |
Why?
|
Radionuclide Imaging | 5 | 1996 | 1972 | 0.030 |
Why?
|
Cerebral Ventriculography | 2 | 1985 | 44 | 0.030 |
Why?
|
Cats | 3 | 1985 | 975 | 0.030 |
Why?
|
Propofol | 1 | 2000 | 602 | 0.030 |
Why?
|
Glycosylation | 1 | 1997 | 1098 | 0.030 |
Why?
|
Medical Records | 2 | 2010 | 1407 | 0.030 |
Why?
|
Pneumoencephalography | 2 | 1984 | 22 | 0.030 |
Why?
|
Oximes | 2 | 1994 | 303 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2000 | 1492 | 0.030 |
Why?
|
Chloramphenicol | 1 | 1973 | 67 | 0.030 |
Why?
|
Molecular Biology | 1 | 1997 | 575 | 0.030 |
Why?
|
Nafcillin | 1 | 1973 | 23 | 0.030 |
Why?
|
Autoimmune Diseases | 2 | 2004 | 2238 | 0.030 |
Why?
|
PUVA Therapy | 1 | 1993 | 101 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 2 | 2009 | 183 | 0.030 |
Why?
|
Motor Skills | 2 | 1986 | 521 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2000 | 997 | 0.030 |
Why?
|
Linear Models | 3 | 2006 | 5866 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1994 | 255 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1993 | 306 | 0.030 |
Why?
|
Laminectomy | 1 | 1994 | 225 | 0.030 |
Why?
|
Diethylstilbestrol | 2 | 1990 | 87 | 0.030 |
Why?
|
Massachusetts | 4 | 2006 | 8833 | 0.030 |
Why?
|
Mutagenesis | 1 | 1997 | 1230 | 0.030 |
Why?
|
Methicillin | 1 | 1973 | 62 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1996 | 773 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2000 | 1803 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2002 | 2073 | 0.030 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1993 | 174 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 3800 | 0.030 |
Why?
|
Myelography | 2 | 1985 | 72 | 0.030 |
Why?
|
Ligands | 1 | 2000 | 3268 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2004 | 2789 | 0.030 |
Why?
|
Vasopressins | 2 | 1985 | 351 | 0.030 |
Why?
|
Galactorrhea | 1 | 1992 | 23 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 1997 | 797 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2001 | 1683 | 0.030 |
Why?
|
Phantoms, Imaging | 2 | 2000 | 2518 | 0.030 |
Why?
|
Anesthesia | 2 | 2002 | 1591 | 0.030 |
Why?
|
Cell Lineage | 1 | 2001 | 2554 | 0.030 |
Why?
|
Brain Abscess | 1 | 1973 | 120 | 0.030 |
Why?
|
Spinal Neoplasms | 2 | 1994 | 703 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 11874 | 0.030 |
Why?
|
Spectrophotometry | 1 | 1992 | 309 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2001 | 2417 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1995 | 1122 | 0.030 |
Why?
|
Ki-67 Antigen | 2 | 2005 | 627 | 0.020 |
Why?
|
Arteries | 1 | 1997 | 1122 | 0.020 |
Why?
|
Mast Cells | 1 | 1999 | 1392 | 0.020 |
Why?
|
Analysis of Variance | 4 | 2005 | 6224 | 0.020 |
Why?
|
Genotype | 4 | 2010 | 12978 | 0.020 |
Why?
|
Genes, p53 | 2 | 2007 | 712 | 0.020 |
Why?
|
Sodium-Potassium-Chloride Symporters | 1 | 2012 | 106 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5304 | 0.020 |
Why?
|
Random Allocation | 2 | 2005 | 2392 | 0.020 |
Why?
|
Histocytochemistry | 3 | 1988 | 696 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 1996 | 676 | 0.020 |
Why?
|
Blood-Brain Barrier | 2 | 1992 | 1027 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2014 | 424 | 0.020 |
Why?
|
Cohort Studies | 2 | 2005 | 41457 | 0.020 |
Why?
|
Telomere | 1 | 1998 | 940 | 0.020 |
Why?
|
Elasticity | 2 | 2004 | 655 | 0.020 |
Why?
|
Oncogenes | 1 | 1997 | 1221 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2012 | 2913 | 0.020 |
Why?
|
Laser Coagulation | 1 | 1993 | 330 | 0.020 |
Why?
|
Technetium Tc 99m Exametazime | 3 | 1998 | 61 | 0.020 |
Why?
|
Attitude to Health | 1 | 2000 | 2024 | 0.020 |
Why?
|
Subdural Space | 3 | 1995 | 38 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2005 | 3979 | 0.020 |
Why?
|
Arginine | 2 | 1994 | 933 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2001 | 3392 | 0.020 |
Why?
|
Cerebral Arteries | 2 | 1984 | 490 | 0.020 |
Why?
|
Cephalometry | 1 | 1992 | 382 | 0.020 |
Why?
|
Methotrexate | 1 | 1998 | 1716 | 0.020 |
Why?
|
Ureteral Neoplasms | 1 | 2012 | 107 | 0.020 |
Why?
|
Menstruation Disturbances | 1 | 1992 | 143 | 0.020 |
Why?
|
Electrodes, Implanted | 3 | 2005 | 838 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2008 | 5780 | 0.020 |
Why?
|
Lymphocytes | 2 | 1997 | 2604 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 1995 | 1386 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5367 | 0.020 |
Why?
|
Chromosome Mapping | 4 | 2007 | 4611 | 0.020 |
Why?
|
Torticollis | 1 | 1991 | 64 | 0.020 |
Why?
|
Amenorrhea | 1 | 1994 | 483 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 1984 | 3879 | 0.020 |
Why?
|
Fatal Outcome | 2 | 2008 | 1835 | 0.020 |
Why?
|
Cyclophosphamide | 3 | 2007 | 2218 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 1994 | 747 | 0.020 |
Why?
|
Interviews as Topic | 1 | 1998 | 2697 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 1997 | 1404 | 0.020 |
Why?
|
Pituitary Gland, Posterior | 2 | 1990 | 42 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1503 | 0.020 |
Why?
|
Receptors, GABA | 1 | 2012 | 313 | 0.020 |
Why?
|
Penicillins | 1 | 1973 | 402 | 0.020 |
Why?
|
Immunotherapy | 2 | 2003 | 4642 | 0.020 |
Why?
|
Affect | 1 | 1998 | 1486 | 0.020 |
Why?
|
Diuretics, Osmotic | 2 | 1979 | 33 | 0.020 |
Why?
|
Tissue Donors | 2 | 1991 | 2331 | 0.020 |
Why?
|
Caspase 3 | 2 | 2004 | 731 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 712 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2637 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4845 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2011 | 316 | 0.020 |
Why?
|
Orthopedic Fixation Devices | 1 | 1989 | 76 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3688 | 0.020 |
Why?
|
Dextrans | 1 | 2011 | 573 | 0.020 |
Why?
|
Karyotyping | 2 | 2001 | 1171 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2012 | 925 | 0.020 |
Why?
|
Meningism | 1 | 1989 | 1 | 0.020 |
Why?
|
Bleomycin | 1 | 2010 | 494 | 0.020 |
Why?
|
Registries | 1 | 2005 | 8207 | 0.020 |
Why?
|
Heart Diseases | 1 | 2002 | 2778 | 0.020 |
Why?
|
Benzamides | 2 | 2009 | 1371 | 0.020 |
Why?
|
Arteriovenous Fistula | 1 | 1973 | 319 | 0.020 |
Why?
|
Technetium Compounds | 1 | 1989 | 15 | 0.020 |
Why?
|
Osteomyelitis | 1 | 1993 | 407 | 0.020 |
Why?
|
Melanoma | 2 | 2005 | 5697 | 0.020 |
Why?
|
Symporters | 1 | 2012 | 363 | 0.020 |
Why?
|
Caspases | 2 | 2004 | 878 | 0.020 |
Why?
|
Inositol | 1 | 2010 | 215 | 0.020 |
Why?
|
Regression Analysis | 2 | 2010 | 6338 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 2 | 2007 | 1113 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1990 | 370 | 0.020 |
Why?
|
Sarcoidosis | 2 | 1989 | 521 | 0.020 |
Why?
|
France | 1 | 1990 | 492 | 0.020 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1989 | 302 | 0.020 |
Why?
|
Signal Transduction | 3 | 2005 | 23416 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2002 | 12334 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 1994 | 1092 | 0.020 |
Why?
|
Hemianopsia | 1 | 1990 | 121 | 0.020 |
Why?
|
Orchiectomy | 1 | 2010 | 463 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2008 | 206 | 0.020 |
Why?
|
Data Mining | 1 | 2013 | 551 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2009 | 210 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 2 | 1987 | 726 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1989 | 418 | 0.020 |
Why?
|
Cyclin H | 1 | 2007 | 5 | 0.020 |
Why?
|
Structure-Activity Relationship | 2 | 2006 | 3074 | 0.020 |
Why?
|
Personal Autonomy | 1 | 1990 | 304 | 0.020 |
Why?
|
Nausea | 1 | 1991 | 679 | 0.020 |
Why?
|
Anesthesia, General | 1 | 1995 | 1173 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2118 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2008 | 174 | 0.020 |
Why?
|
von Hippel-Lindau Disease | 1 | 1989 | 151 | 0.020 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2008 | 179 | 0.020 |
Why?
|
Cyclin D | 1 | 2007 | 72 | 0.020 |
Why?
|
Nitric Oxide | 2 | 1994 | 2135 | 0.020 |
Why?
|
Treatment Failure | 3 | 2003 | 2635 | 0.020 |
Why?
|
3T3 Cells | 2 | 2000 | 1085 | 0.020 |
Why?
|
Hypesthesia | 1 | 2008 | 107 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2000 | 7050 | 0.020 |
Why?
|
Gastrointestinal Transit | 1 | 2008 | 100 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2014 | 15828 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 2 | 1987 | 618 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 1993 | 976 | 0.020 |
Why?
|
Age of Onset | 1 | 1994 | 3302 | 0.020 |
Why?
|
Pyrazoles | 2 | 2008 | 2008 | 0.020 |
Why?
|
Skull | 1 | 2011 | 818 | 0.020 |
Why?
|
Caspase 8 | 1 | 2007 | 190 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 283 | 0.020 |
Why?
|
Probability | 2 | 2003 | 2475 | 0.020 |
Why?
|
Aphasia, Wernicke | 1 | 1986 | 19 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2007 | 71 | 0.020 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 1987 | 87 | 0.020 |
Why?
|
Eye Neoplasms | 1 | 1989 | 307 | 0.020 |
Why?
|
Diabetes Insipidus | 1 | 1987 | 144 | 0.020 |
Why?
|
Longevity | 1 | 2014 | 1064 | 0.020 |
Why?
|
Beauty Culture | 1 | 2006 | 41 | 0.020 |
Why?
|
Complement System Proteins | 1 | 1989 | 734 | 0.020 |
Why?
|
Hematopoiesis | 1 | 1996 | 2049 | 0.020 |
Why?
|
Aphasia, Broca | 1 | 1986 | 52 | 0.020 |
Why?
|
Drug Resistance | 1 | 1992 | 1594 | 0.020 |
Why?
|
Injections, Intralesional | 2 | 1998 | 280 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 360 | 0.020 |
Why?
|
Infusion Pumps, Implantable | 1 | 2007 | 158 | 0.020 |
Why?
|
History, Ancient | 1 | 1986 | 212 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2010 | 491 | 0.020 |
Why?
|
Carotid Artery Diseases | 1 | 1973 | 877 | 0.020 |
Why?
|
Acclimatization | 1 | 1986 | 113 | 0.020 |
Why?
|
Substantia Nigra | 1 | 1988 | 350 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 1990 | 718 | 0.020 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2006 | 56 | 0.020 |
Why?
|
Retinoblastoma | 1 | 1989 | 317 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 1987 | 262 | 0.020 |
Why?
|
Cerebral Angiography | 4 | 1985 | 1281 | 0.020 |
Why?
|
Paraplegia | 1 | 1986 | 161 | 0.020 |
Why?
|
Retroperitoneal Space | 1 | 2006 | 170 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1995 | 2894 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2006 | 90 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 2006 | 197 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 1999 | 4745 | 0.020 |
Why?
|
Ophthalmoplegia | 1 | 1987 | 168 | 0.020 |
Why?
|
alpha-Fetoproteins | 1 | 2006 | 222 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 2007 | 213 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1989 | 1349 | 0.020 |
Why?
|
Melanocyte-Stimulating Hormones | 1 | 1985 | 25 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1217 | 0.020 |
Why?
|
Ear Canal | 1 | 2006 | 147 | 0.020 |
Why?
|
Government Regulation | 1 | 1990 | 524 | 0.020 |
Why?
|
Anions | 1 | 1985 | 136 | 0.020 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2008 | 446 | 0.020 |
Why?
|
Memory Disorders | 2 | 1985 | 1197 | 0.020 |
Why?
|
Heart Atria | 2 | 1982 | 1333 | 0.020 |
Why?
|
Ataxia | 1 | 2008 | 306 | 0.020 |
Why?
|
Mental Disorders | 1 | 2005 | 6826 | 0.020 |
Why?
|
Absorption | 1 | 1985 | 242 | 0.020 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 1985 | 9 | 0.020 |
Why?
|
Mathematics | 1 | 1986 | 707 | 0.020 |
Why?
|
Dog Diseases | 2 | 1983 | 141 | 0.020 |
Why?
|
Pathology, Surgical | 1 | 2006 | 151 | 0.020 |
Why?
|
Epoxide Hydrolases | 1 | 2006 | 122 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 1998 | 3451 | 0.020 |
Why?
|
Guanine | 1 | 2006 | 278 | 0.020 |
Why?
|
Cefotaxime | 1 | 1984 | 35 | 0.020 |
Why?
|
Cyclins | 1 | 2007 | 594 | 0.020 |
Why?
|
Lectins | 1 | 1987 | 489 | 0.020 |
Why?
|
Biological Factors | 1 | 2006 | 157 | 0.020 |
Why?
|
Acute Disease | 2 | 1986 | 7237 | 0.020 |
Why?
|
Speech | 2 | 2004 | 555 | 0.020 |
Why?
|
Syndrome | 2 | 1994 | 3268 | 0.020 |
Why?
|
Kaolin | 1 | 1984 | 16 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2007 | 368 | 0.020 |
Why?
|
Brain Stem | 1 | 1990 | 858 | 0.020 |
Why?
|
Educational Status | 2 | 2003 | 2509 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1988 | 454 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 2005 | 225 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 669 | 0.010 |
Why?
|
Melatonin | 1 | 1990 | 669 | 0.010 |
Why?
|
Comorbidity | 2 | 2013 | 10505 | 0.010 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 244 | 0.010 |
Why?
|
Brain Stem Neoplasms | 1 | 2006 | 190 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2005 | 426 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1990 | 1226 | 0.010 |
Why?
|
Phlebography | 1 | 1986 | 326 | 0.010 |
Why?
|
Vasa Vasorum | 1 | 1984 | 25 | 0.010 |
Why?
|
Aphasia | 1 | 1986 | 192 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 1985 | 289 | 0.010 |
Why?
|
DNA | 1 | 1998 | 7196 | 0.010 |
Why?
|
Software Validation | 1 | 2004 | 59 | 0.010 |
Why?
|
Reflex, Pupillary | 1 | 1984 | 62 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 1988 | 1148 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1748 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 1995 | 4739 | 0.010 |
Why?
|
Macrophages | 1 | 1999 | 5758 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 361 | 0.010 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2004 | 141 | 0.010 |
Why?
|
Histological Techniques | 1 | 2004 | 194 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1991 | 1141 | 0.010 |
Why?
|
Neurofibromatosis 2 | 1 | 2007 | 383 | 0.010 |
Why?
|
Referral and Consultation | 1 | 1997 | 3599 | 0.010 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2004 | 203 | 0.010 |
Why?
|
Metabolome | 1 | 2011 | 987 | 0.010 |
Why?
|
Patient Discharge | 1 | 1997 | 3442 | 0.010 |
Why?
|
Body Weights and Measures | 1 | 2004 | 208 | 0.010 |
Why?
|
Blinking | 1 | 1984 | 133 | 0.010 |
Why?
|
Income | 2 | 2003 | 1870 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 613 | 0.010 |
Why?
|
Extracellular Space | 1 | 1985 | 562 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1986 | 1623 | 0.010 |
Why?
|
Neurofibromatosis 1 | 1 | 1989 | 560 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1997 | 3239 | 0.010 |
Why?
|
Aging | 2 | 1996 | 8699 | 0.010 |
Why?
|
Vision Disorders | 2 | 1990 | 1088 | 0.010 |
Why?
|
Inflammation | 2 | 2002 | 10760 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2000 | 7847 | 0.010 |
Why?
|
Telencephalon | 1 | 2004 | 141 | 0.010 |
Why?
|
Multigene Family | 1 | 2006 | 1076 | 0.010 |
Why?
|
Aminophylline | 1 | 1983 | 41 | 0.010 |
Why?
|
Autoradiography | 2 | 1997 | 728 | 0.010 |
Why?
|
Papaverine | 1 | 1983 | 45 | 0.010 |
Why?
|
Particle Size | 1 | 2007 | 1648 | 0.010 |
Why?
|
Occipital Lobe | 1 | 1985 | 374 | 0.010 |
Why?
|
Neurophysins | 1 | 1982 | 14 | 0.010 |
Why?
|
Iron | 1 | 2011 | 1790 | 0.010 |
Why?
|
Pituitary Hormone-Releasing Hormones | 1 | 1982 | 36 | 0.010 |
Why?
|
Intercellular Junctions | 2 | 1984 | 195 | 0.010 |
Why?
|
Meningitis | 1 | 1984 | 217 | 0.010 |
Why?
|
Electromyography | 1 | 2008 | 1393 | 0.010 |
Why?
|
Glutathione S-Transferase pi | 1 | 2003 | 99 | 0.010 |
Why?
|
Contraceptives, Oral | 1 | 2005 | 553 | 0.010 |
Why?
|
Food Industry | 1 | 2003 | 66 | 0.010 |
Why?
|
Indium | 1 | 1982 | 47 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 546 | 0.010 |
Why?
|
Pedigree | 2 | 2003 | 4539 | 0.010 |
Why?
|
Hematoma | 1 | 2007 | 762 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1759 | 0.010 |
Why?
|
Menarche | 1 | 2005 | 532 | 0.010 |
Why?
|
Cerebellum | 2 | 2000 | 1501 | 0.010 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 1982 | 72 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2008 | 833 | 0.010 |
Why?
|
Graft Survival | 2 | 1994 | 3820 | 0.010 |
Why?
|
Peritoneal Cavity | 1 | 1982 | 135 | 0.010 |
Why?
|
Hypopituitarism | 2 | 1998 | 250 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2007 | 774 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 558 | 0.010 |
Why?
|
Corpus Striatum | 1 | 1988 | 1235 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1999 | 10175 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1242 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2009 | 1349 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 1982 | 178 | 0.010 |
Why?
|
Choroid Plexus | 1 | 1984 | 240 | 0.010 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2830 | 0.010 |
Why?
|
Marital Status | 1 | 2003 | 425 | 0.010 |
Why?
|
Central Nervous System | 1 | 1989 | 1333 | 0.010 |
Why?
|
Exons | 1 | 2007 | 2381 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1970 | 0.010 |
Why?
|
Oxytocin | 1 | 1985 | 402 | 0.010 |
Why?
|
Respiration | 2 | 1985 | 1656 | 0.010 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2002 | 198 | 0.010 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2001 | 119 | 0.010 |
Why?
|
Haplotypes | 1 | 2007 | 2713 | 0.010 |
Why?
|
Cyclin E | 1 | 2001 | 155 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2007 | 2509 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 1981 | 111 | 0.010 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2005 | 549 | 0.010 |
Why?
|
Semantics | 1 | 2005 | 612 | 0.010 |
Why?
|
Hippocampus | 2 | 1996 | 3761 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 2 | 1979 | 1879 | 0.010 |
Why?
|
Radioisotopes | 1 | 1982 | 499 | 0.010 |
Why?
|
Parturition | 1 | 2004 | 447 | 0.010 |
Why?
|
Sphenoid Sinus | 1 | 2001 | 99 | 0.010 |
Why?
|
Angiography | 1 | 1986 | 1596 | 0.010 |
Why?
|
Protein Kinases | 1 | 2007 | 1606 | 0.010 |
Why?
|
Prostaglandin D2 | 1 | 2000 | 108 | 0.010 |
Why?
|
Mice, Inbred BALB C | 2 | 2000 | 6188 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2008 | 1872 | 0.010 |
Why?
|
Genes, erbB-1 | 1 | 2000 | 162 | 0.010 |
Why?
|
Mechlorethamine | 1 | 1979 | 129 | 0.010 |
Why?
|
Withholding Treatment | 1 | 1984 | 616 | 0.010 |
Why?
|
Permeability | 1 | 1982 | 721 | 0.010 |
Why?
|
Anura | 1 | 1979 | 80 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2000 | 237 | 0.010 |
Why?
|
Kidney | 1 | 1995 | 7045 | 0.010 |
Why?
|
Tomography | 1 | 1982 | 411 | 0.010 |
Why?
|
Atrophy | 1 | 1985 | 1631 | 0.010 |
Why?
|
Religion | 1 | 2003 | 372 | 0.010 |
Why?
|
Phosphorylcholine | 1 | 2000 | 153 | 0.010 |
Why?
|
Synaptophysin | 1 | 1999 | 139 | 0.010 |
Why?
|
Dexamethasone | 2 | 1994 | 1947 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2001 | 412 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2001 | 451 | 0.010 |
Why?
|
Radio Waves | 1 | 2001 | 251 | 0.010 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 1995 | 246 | 0.010 |
Why?
|
Hormone Antagonists | 1 | 1999 | 106 | 0.010 |
Why?
|
Desmosomes | 1 | 1979 | 72 | 0.010 |
Why?
|
Lactates | 1 | 2000 | 404 | 0.010 |
Why?
|
Echoencephalography | 1 | 1979 | 134 | 0.010 |
Why?
|
Internationality | 1 | 2005 | 1000 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 1995 | 2630 | 0.010 |
Why?
|
Gliosis | 1 | 2000 | 245 | 0.010 |
Why?
|
Anisotropy | 1 | 2002 | 1283 | 0.010 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2000 | 318 | 0.010 |
Why?
|
Micropore Filters | 1 | 1978 | 22 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 2000 | 526 | 0.010 |
Why?
|
Cryotherapy | 1 | 2000 | 159 | 0.010 |
Why?
|
Dogs | 4 | 1985 | 3838 | 0.010 |
Why?
|
Haplorhini | 1 | 1979 | 525 | 0.010 |
Why?
|
Data Display | 1 | 1999 | 175 | 0.010 |
Why?
|
Chemokines | 1 | 2003 | 954 | 0.010 |
Why?
|
Electrophysiology | 1 | 1982 | 1262 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1990 | 2569 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1983 | 748 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2278 | 0.010 |
Why?
|
Radiopharmaceuticals | 2 | 1998 | 2650 | 0.010 |
Why?
|
Carboplatin | 1 | 2001 | 793 | 0.010 |
Why?
|
Biomedical Engineering | 1 | 2000 | 286 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2005 | 1987 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1988 | 1405 | 0.010 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1997 | 55 | 0.010 |
Why?
|
Reaction Time | 1 | 2005 | 2087 | 0.010 |
Why?
|
Cytokines | 2 | 2009 | 7373 | 0.010 |
Why?
|
Culture Techniques | 1 | 1978 | 531 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1643 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 1993 | 13382 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1998 | 228 | 0.010 |
Why?
|
Mutation | 3 | 2010 | 30016 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2001 | 655 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1985 | 1474 | 0.010 |
Why?
|
Movement | 1 | 2004 | 1476 | 0.010 |
Why?
|
Femoral Artery | 1 | 1982 | 826 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8311 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2001 | 671 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7960 | 0.010 |
Why?
|
Recovery of Function | 1 | 2008 | 2978 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2001 | 561 | 0.010 |
Why?
|
Cauda Equina | 1 | 1977 | 45 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1997 | 212 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 1999 | 333 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2006 | 1890 | 0.010 |
Why?
|
Radiation Injuries | 2 | 1995 | 1189 | 0.010 |
Why?
|
Long-Term Care | 1 | 2001 | 631 | 0.010 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 1997 | 54 | 0.010 |
Why?
|
Menopause | 1 | 2005 | 1645 | 0.010 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 283 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1978 | 218 | 0.010 |
Why?
|
Growth Hormone | 2 | 1990 | 569 | 0.010 |
Why?
|
Endoscopes | 1 | 1997 | 168 | 0.010 |
Why?
|
Fentanyl | 1 | 2000 | 433 | 0.010 |
Why?
|
DNA Damage | 1 | 2006 | 2446 | 0.010 |
Why?
|
Hospices | 1 | 1979 | 245 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 5863 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1984 | 1389 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2011 | 2574 | 0.010 |
Why?
|
Injections, Spinal | 1 | 1997 | 317 | 0.010 |
Why?
|
Mice, SCID | 1 | 2001 | 2625 | 0.010 |
Why?
|
Patients | 1 | 2002 | 906 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4117 | 0.010 |
Why?
|
Testosterone | 1 | 1987 | 2472 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 1984 | 962 | 0.010 |
Why?
|
Cytodiagnosis | 1 | 1979 | 447 | 0.010 |
Why?
|
Telemetry | 1 | 1997 | 199 | 0.010 |
Why?
|
Edema | 1 | 1979 | 765 | 0.010 |
Why?
|
Ethmoid Sinusitis | 1 | 1995 | 25 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1997 | 1058 | 0.010 |
Why?
|
Carotid Arteries | 2 | 1986 | 941 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2002 | 1315 | 0.010 |
Why?
|
Cost Control | 1 | 1997 | 627 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4250 | 0.010 |
Why?
|
Constipation | 1 | 2000 | 563 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2689 | 0.010 |
Why?
|
Maxillary Sinusitis | 1 | 1995 | 41 | 0.010 |
Why?
|
Hematocrit | 1 | 1996 | 623 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1995 | 174 | 0.010 |
Why?
|
Observer Variation | 1 | 2001 | 2606 | 0.010 |
Why?
|
Gait | 1 | 1980 | 811 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2270 | 0.010 |
Why?
|
Hypothermia, Induced | 1 | 1979 | 753 | 0.010 |
Why?
|
HeLa Cells | 1 | 2000 | 3087 | 0.010 |
Why?
|
omega-N-Methylarginine | 1 | 1994 | 108 | 0.010 |
Why?
|
Rats, Nude | 1 | 1994 | 105 | 0.010 |
Why?
|
Computer Graphics | 1 | 1996 | 340 | 0.010 |
Why?
|
Pulmonary Atelectasis | 1 | 1995 | 143 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2000 | 709 | 0.010 |
Why?
|
Psychotropic Drugs | 1 | 1979 | 888 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2000 | 1263 | 0.010 |
Why?
|
Pharynx | 1 | 1996 | 432 | 0.010 |
Why?
|
Penicillin Resistance | 1 | 1973 | 74 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 1994 | 260 | 0.010 |
Why?
|
Research Design | 2 | 2004 | 6174 | 0.010 |
Why?
|
Cell Communication | 1 | 1980 | 1654 | 0.010 |
Why?
|
Family | 1 | 1984 | 3193 | 0.010 |
Why?
|
Sheep | 2 | 1986 | 1436 | 0.010 |
Why?
|
Platelet Count | 1 | 1996 | 780 | 0.010 |
Why?
|
Particle Accelerators | 1 | 1994 | 174 | 0.010 |
Why?
|
Morbidity | 1 | 1998 | 1750 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2003 | 2090 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1979 | 2328 | 0.010 |
Why?
|
Models, Genetic | 1 | 2003 | 3431 | 0.010 |
Why?
|
Radiotherapy | 1 | 1979 | 1497 | 0.010 |
Why?
|
Area Under Curve | 1 | 1997 | 1635 | 0.010 |
Why?
|
Ultrasonography | 1 | 1986 | 5964 | 0.010 |
Why?
|
Analgesics | 1 | 1979 | 1066 | 0.010 |
Why?
|
Methods | 1 | 1973 | 1065 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16571 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 14389 | 0.010 |
Why?
|
Brain Ischemia | 1 | 1985 | 3028 | 0.010 |
Why?
|
Genetic Variation | 1 | 2007 | 6561 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1996 | 1597 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1994 | 783 | 0.010 |
Why?
|
Debridement | 1 | 1994 | 493 | 0.010 |
Why?
|
Vomiting | 1 | 1995 | 651 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1997 | 3591 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1995 | 1900 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2000 | 2425 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1496 | 0.010 |
Why?
|
Cough | 1 | 1995 | 595 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1996 | 2112 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2001 | 2917 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1991 | 229 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2002 | 3567 | 0.010 |
Why?
|
Insurance, Health | 1 | 2003 | 2495 | 0.010 |
Why?
|
Drug Therapy | 1 | 1994 | 503 | 0.010 |
Why?
|
Verapamil | 1 | 1991 | 242 | 0.010 |
Why?
|
Median Eminence | 1 | 1990 | 28 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22115 | 0.010 |
Why?
|
Galanin | 1 | 1990 | 42 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2003 | 2518 | 0.010 |
Why?
|
Vena Cava Filters | 1 | 1993 | 261 | 0.010 |
Why?
|
Alopecia | 1 | 1994 | 412 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1081 | 0.010 |
Why?
|
Airway Obstruction | 1 | 1995 | 661 | 0.010 |
Why?
|
Medicine | 1 | 1978 | 942 | 0.010 |
Why?
|
Gene Rearrangement | 1 | 1995 | 1125 | 0.010 |
Why?
|
Proto-Oncogenes | 1 | 1990 | 321 | 0.010 |
Why?
|
Suture Techniques | 1 | 1994 | 768 | 0.010 |
Why?
|
Antimony | 1 | 1989 | 20 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2000 | 2827 | 0.010 |
Why?
|
Colloids | 1 | 1989 | 123 | 0.000 |
Why?
|
Acetylcholine | 1 | 1991 | 629 | 0.000 |
Why?
|
Lipids | 1 | 2000 | 3332 | 0.000 |
Why?
|
Technetium | 1 | 1989 | 317 | 0.000 |
Why?
|
Disabled Persons | 1 | 1998 | 1226 | 0.000 |
Why?
|
Golgi Apparatus | 1 | 1990 | 404 | 0.000 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1988 | 95 | 0.000 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1988 | 139 | 0.000 |
Why?
|
Follicle Stimulating Hormone, beta Subunit | 1 | 1987 | 58 | 0.000 |
Why?
|
Blood Cells | 1 | 1989 | 305 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1990 | 573 | 0.000 |
Why?
|
Antigens, CD | 1 | 1998 | 3998 | 0.000 |
Why?
|
Whole-Body Irradiation | 1 | 1988 | 432 | 0.000 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 3085 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1988 | 411 | 0.000 |
Why?
|
Emergencies | 1 | 1994 | 1217 | 0.000 |
Why?
|
Intubation, Intratracheal | 1 | 1995 | 1331 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 2001 | 7798 | 0.000 |
Why?
|
Headache | 1 | 1995 | 1255 | 0.000 |
Why?
|
Hyperplasia | 1 | 1990 | 1150 | 0.000 |
Why?
|
Vasodilation | 1 | 1991 | 962 | 0.000 |
Why?
|
Microbial Sensitivity Tests | 1 | 1973 | 1936 | 0.000 |
Why?
|
Cisterna Magna | 1 | 1986 | 39 | 0.000 |
Why?
|
Constriction | 1 | 1986 | 168 | 0.000 |
Why?
|
Serotonin | 1 | 1991 | 1041 | 0.000 |
Why?
|
Sodium Pertechnetate Tc 99m | 1 | 1985 | 54 | 0.000 |
Why?
|
Iodides | 1 | 1985 | 40 | 0.000 |
Why?
|
beta-Endorphin | 1 | 1985 | 43 | 0.000 |
Why?
|
Receptors, Opioid | 1 | 1985 | 145 | 0.000 |
Why?
|
Radiation Dosage | 1 | 1994 | 1956 | 0.000 |
Why?
|
Meningitis, Haemophilus | 1 | 1984 | 20 | 0.000 |
Why?
|
Ligation | 1 | 1986 | 447 | 0.000 |
Why?
|
Calcinosis | 1 | 1994 | 1469 | 0.000 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 1994 | 1655 | 0.000 |
Why?
|
Organ Size | 1 | 1990 | 2252 | 0.000 |
Why?
|
Serratia marcescens | 1 | 1984 | 46 | 0.000 |
Why?
|
Coronary Artery Bypass | 1 | 1994 | 2188 | 0.000 |
Why?
|
Palliative Care | 1 | 1979 | 3592 | 0.000 |
Why?
|
Anticoagulants | 2 | 1993 | 4785 | 0.000 |
Why?
|
Dura Mater | 1 | 1986 | 290 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 2003 | 5812 | 0.000 |
Why?
|
Thyrotropin | 1 | 1987 | 834 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1979 | 4488 | 0.000 |
Why?
|
Catheters, Indwelling | 1 | 1986 | 426 | 0.000 |
Why?
|
Chronic Disease | 1 | 1998 | 9311 | 0.000 |
Why?
|
Klebsiella Infections | 1 | 1984 | 144 | 0.000 |
Why?
|
Vertebral Artery | 1 | 1984 | 184 | 0.000 |
Why?
|
Asthma | 1 | 2002 | 6233 | 0.000 |
Why?
|
Wound Healing | 1 | 1994 | 2802 | 0.000 |
Why?
|
Vena Cava, Inferior | 1 | 1986 | 458 | 0.000 |
Why?
|
Enterobacteriaceae Infections | 1 | 1984 | 188 | 0.000 |
Why?
|
Klebsiella pneumoniae | 1 | 1984 | 249 | 0.000 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2000 | 5672 | 0.000 |
Why?
|
Endothelium | 1 | 1984 | 764 | 0.000 |
Why?
|
Carotid Artery, Internal | 1 | 1984 | 445 | 0.000 |
Why?
|
Perfusion | 1 | 1986 | 1373 | 0.000 |
Why?
|
Leukocytes | 1 | 1989 | 2023 | 0.000 |
Why?
|
Pons | 1 | 1982 | 240 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2003 | 11106 | 0.000 |
Why?
|
Catheterization | 1 | 1986 | 1428 | 0.000 |
Why?
|
Cerebral Infarction | 1 | 1985 | 980 | 0.000 |
Why?
|
Escherichia coli Infections | 1 | 1984 | 518 | 0.000 |
Why?
|
Cell Membrane | 1 | 1989 | 3680 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1987 | 1265 | 0.000 |
Why?
|
Shock, Septic | 1 | 1986 | 769 | 0.000 |
Why?
|
Constriction, Pathologic | 1 | 1983 | 1096 | 0.000 |
Why?
|
Blood | 1 | 1980 | 596 | 0.000 |
Why?
|
Kinetics | 1 | 1985 | 6370 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1993 | 10199 | 0.000 |
Why?
|